Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Carbylan raises $65M in downsized IPO

    Carbylan Therapeutics Inc. (NASDAQ:CBYL) raised $65 million through the sale of 13 million shares at $5 in a downsized IPO on Wednesday. The price values the company at $121.2 million. In January, Carbylan proposed to …

    Published on 4/8/2015
  • FINANCIAL NEWS: Follow-on roundup: Dyax, Prothena

    Dyax Corp. (NASDAQ:DYAX) and Prothena Corp. plc (NASDAQ:PRTA) raised $321.9 million in follow-on offerings on Wednesday.Dyax raised $199.8 million through the sale of 7.4 million shares at $27 in a deal underwritten by …

    Published on 4/8/2015
  • FINANCIAL NEWS: SanBio falls on first trading day

    Cell therapy company SanBio Co. Ltd. (Tokyo:4592) fell Y227 (11%) to Y1,773 in its first day of trading Wednesday after raising Y8 billion ($67.2 million) through the sale of 4 million shares at Y2,000 in an IPO. SanBio…

    Published on 4/8/2015
  • FINANCIAL NEWS: Ark Biosciences raises series A round

    Antiviral company Ark Biosciences Inc. (Shanghai, China) raised a series A round of undisclosed size. New investors Qiming Venture Partners and Morningside led the round, and existing investor TF Capital also …

    Published on 4/7/2015
  • FINANCIAL NEWS: Cerulean raises $35M in follow-on

    Oncology company Cerulean Pharma Inc. (NASDAQ:CERU) raised $35 million through the sale of 5.8 million shares at $6 in a follow-on underwritten by Leerink; Barclays; Canaccord Genuity; JMP Securities; and Wedbush …

    Published on 4/7/2015
  • FINANCIAL NEWS: Loncar unveils cancer immunotherapy index

    Loncar Investments LLC launched the Loncar Cancer Immunotherapy Index (LCINDX), an equal-weighted index that tracks the performance of 25 biopharma companies developing or marketing cancer immunotherapies. The index …

    Published on 4/7/2015
  • FINANCIAL NEWS: Nabriva raises $50M

    Nabriva Therapeutics AG (Vienna, Austria) raised $50 million in the first tranche of a planned $120 million series B round. New investors Vivo Capital and OrbiMed led the round. New investors EcoR1 Capital and Boxer …

    Published on 4/7/2015
  • FINANCIAL NEWS: Natera raises $55.5M series F round

    Diagnostics company Natera Inc. (San Carlos, Calif.) raised $55.5 million in a series F round led by Sofinnova Ventures. Capital Research and Management; Franklin Templeton Investments; Jennison Associates; RA Capital; …

    Published on 4/6/2015
  • FINANCIAL NEWS: Caribou raises $11M in series A

    Gene editing company Caribou Biosciences Inc. (Berkeley, Calif.) raised $11 million in an untranched series A round from Fidelity Bioscience; Novartis; Mission Bay Capital; 5 Prime Ventures; and an undisclosed strategic…

    Published on 4/2/2015
  • FINANCIAL NEWS: Financial tracks

    MPM Capital hired Anthony Rosenberg as managing director. Rosenberg was global head of M&A and licensing at Novartis AG (NYSE:NVS; SIX:NOVN).Frazier Healthcare named Richard Maroun as an operating executive on its …

    Published on 4/2/2015
  • FINANCIAL NEWS: Funding roundup: Raptor, Conatus, Silence, Northwest, Trinity, Egalet

    Rare disease play Raptor Pharmaceutical Corp. (NASDAQ:RPTP) raised $85.5 million through the sale of 9.5 million shares at $9 in a follow-on underwritten by Citigroup; Leerink; Cowen; JMP Securities; and Janney …

    Published on 4/2/2015
  • FINANCIAL NEWS: Lux closes $350 venture fund

    Lux Capital raised $350 million for Lux Ventures IV, a new venture fund that will invest in early stage, "futuristic science and technology ventures." Lux said the oversubscribed fund, which had an initial target of $…

    Published on 4/2/2015
  • FINANCIAL NEWS: Coherus raises $120M in follow-on

    Coherus BioSciences Inc. (NASDAQ:CHRS) raised $120 million through the sale of 4.1 million shares at $29 in a follow-on underwritten by JPMorgan; Credit Suisse; and Cowen. Coherus proposed the offering after market …

    Published on 4/1/2015
  • FINANCIAL NEWS: Index raises EUR 650M for growth fund

    Index Ventures raised EUR 650 million ($706.2 million) for a new fund, Index Ventures Growth III, according to a Wednesday SEC filing. Details were not disclosed. The firm invests in tech and life science companies.

    Published on 4/1/2015
  • FINANCIAL NEWS: Arch, Flagship to direct NYC's $150M life sciences fund

    The New York City Economic Development Corp. said Flagship Ventures and Arch Venture Partners will direct investment activities for the Early Stage Life Sciences Funding Initiative, its $150 million life sciences fund. …

    Published on 3/31/2015
  • FINANCIAL NEWS: aTyr raises $76M in series E

    aTyr Pharma Inc. (San Diego, Calif.) raised $76 million in a series E round led by new investors Sofinnova Ventures and an undisclosed institutional investor. Other new investors included funds and accounts advised by T…

    Published on 3/31/2015
  • FINANCIAL NEWS: Funding roundup: Intercept, Insmed, Synta

    Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Insmed Inc. (NASDAQ:INSM) and Synta Pharmaceuticals Corp. (NASDAQ:SNTA) raised more than $580 million in follow-on offerings on Tuesday. Intercept raised $338.4 million …

    Published on 3/31/2015
  • FINANCIAL NEWS: Thrasos raises $21M in series D

    Thrasos Therapeutics Inc. (Montreal, Quebec) raised $21 million in a series D round led by new investor BDC Capital and existing investor SR One. Current investors Advanced Technology Ventures; Fonds de solidarite FTQ; …

    Published on 3/31/2015
  • FINANCIAL NEWS: Novan raises $50M in mezzanine round

    Novan Inc. (Durham, N.C.) raised $50 million in a mezzanine financing, exceeding the round's initial target of $25 million. New investor Malin Corp. plc (ISE:MLC) led the round and was joined by undisclosed existing …

    Published on 3/30/2015
  • FINANCIAL NEWS: Modest biotech rally ends bumpy week

    Biotech stocks recovered some of the week's losses Friday, ending a turbulent week that included a three-day sell-off in which some investors feared companies in the sector were overvalued (see BioCentury Extra, March …

    Published on 3/27/2015
  • FINANCIAL NEWS: PolyPid withdraws IPO

    PolyPid Ltd. (Petach Tikva, Israel) withdrew its proposed IPO on NASDAQ. CBO Asaf Bar said the company is confident it could have gone public under current market conditions, but anticipates undisclosed milestones in …

    Published on 3/27/2015
  • FINANCIAL NEWS: Cerenis raises EUR 53.4M in Euronext IPO

    Cardiovascular play Cerenis Therapeutics S.A. (Euronext:CEREN) raised EUR 53.4 million ($57.7 million) through the sale of 4.2 million shares at EUR 12.70 in an IPO on Euronext. The IPO price values Cerenis at EUR 225.9…

    Published on 3/26/2015
  • FINANCIAL NEWS: Flagship closes $537M Fund V

    Flagship Ventures closed its oversubscribed Flagship Ventures Fund V at $537 million, exceeding its original target of $300 million. Flagship plans to invest the fund in 25-30 companies, with up to 75% going to …

    Published on 3/26/2015
  • FINANCIAL NEWS: OSE Pharma raises EUR 21.1M in IPO

    OSE Pharma S.A. (Euronext:OSE) raised EUR 21.1 million ($22.8 million) in an IPO through the sale of 2 million shares at EUR 10.80. The price, which was the top of its proposed range of EUR 8-EUR 10.80, values the …

    Published on 3/26/2015
  • FINANCIAL NEWS: Cellectis raises $228.3M, lists in U.S.

    Immunotherapy company Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) lost $2.20 to $39.30 in its first day of trading on NASDAQ on Wednesday after raising $228.3 million through the sale of 5.5 million American Depositary…

    Published on 3/25/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993